Cost-Effectiveness of Different Strategies for the Prevention of Venous Thromboembolism After Total Hip Replacement in China

被引：0
|
作者：
Xiaoyu Yan
Xiaohua Gu
Zhenxing Xu
Houweng Lin
Bin Wu
机构：
[1] Shanghai Jiao Tong University Affiliated Sixth People’s Hospital,Department of Orthopedics
[2] Shanghai Jiao Tong University Affiliated Sixth People’s Hospital,Department of Respiratory Medicine
[3] Shanghai Jiaotong University,Department of Cardiology, Renji Hospital, South Campus, School of Medicine
[4] Shanghai Jiaotong University,Medical Decision and Economic Group, Department of Pharmacy, Renji Hospital, School of Medicine
来源：
Advances in Therapy | 2017年 / 34卷
关键词：
Anticoagulation; Cardiology; Cost-effectiveness analysis; Venous thromboembolism;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：466 / 480
页数：14
相关论文
共 50 条
  • [31] Will Rivaroxaban Be Cost-Effective for Prevention. of Venous Thromboembolism after Total Hip Replacement in US Patients?.
    Kwong, Louis
    Diamantopoulos, Alexander
    Forster, Fiona
    Sengupta, Nishan
    Lees, Michael
    BLOOD, 2008, 112 (11) : 467 - 467
  • [32] PRACTICAL USE OF APIXABAN IN THE PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL KNEE OR HIP REPLACEMENT
    Lassen, M. R.
    DRUGS OF TODAY, 2012, 48 (04) : 249 - 258
  • [33] Cost Effectiveness of Venous Thromboembolism Pharmacological Prophylaxis in Total Hip and Knee Replacement: A Systematic Review
    Plumb, Jonathan M.
    Clemens, Andreas
    Monz, Brigitta U.
    PHARMACOECONOMICS, 2010, 28 (09) : 781 - 782
  • [34] Cost Effectiveness of Venous Thromboembolism Pharmacological Prophylaxis in Total Hip and Knee Replacement: A Systematic Review
    Jonathan M. Plumb
    Andreas Clemens
    Brigitta U. Monz
    PharmacoEconomics, 2010, 28 : 781 - 782
  • [35] Cost Effectiveness of Venous Thromboembolism Pharmacological Prophylaxis in Total Hip and Knee Replacement A Systematic Review
    Kapoor, Alok
    Chuang, Warren
    Radhakrishnan, Nila
    Smith, Kenneth J.
    Berlowitz, Dan
    Segal, Jodi B.
    Katz, Jeffrey N.
    Losina, Elena
    PHARMACOECONOMICS, 2010, 28 (07) : 521 - 538
  • [36] COST-UTILITY ANALYSIS OF RIVAROXABAN COMPARED WITH ENOXAPARIN IN PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL HIP REPLACEMENT IN SLOVAKIA
    Pereira, R.
    Diamantopoulos, A.
    Bielik, J.
    Lees, M.
    Tomek, D.
    Lukac, M.
    VALUE IN HEALTH, 2010, 13 (03) : A166 - A166
  • [37] COST-EFFECTIVENESS OF PROPHYLAXIS IN TOTAL HIP-REPLACEMENT
    PAIEMENT, GD
    WESSINGER, SJ
    HARRIS, WH
    AMERICAN JOURNAL OF SURGERY, 1991, 161 (04): : 519 - 524
  • [38] A COST-EFFECTIVENESS ANALYSIS OF TOTAL HIP-REPLACEMENT
    MUNCK, S
    PEDERSEN, KM
    HELMERHANSEN, HB
    ACTA ORTHOPAEDICA SCANDINAVICA, 1987, 58 (03): : 326 - 327
  • [39] COST-EFFECTIVENESS ANALYSIS OF BEMIPARIN AS PROPHYLAXIS FOR VENOUS THROMBOEMBOLISM IN TOTAL KNEE REPLACEMENT SURGERY IN MEXICO
    Carlos, F.
    Aguirre, A.
    Esquivel, R.
    Nettel, J.
    Meillon, L.
    Bierschwale, H.
    VALUE IN HEALTH, 2012, 15 (07) : A445 - A445
  • [40] Cost-effectiveness of diagnostic strategies for venous thromboembolism: a systematic review
    Zhang, Yuan
    Begum, Housne A.
    Grewal, Himmat
    Etxeandia-Ikobaltzeta, Itziar
    Morgano, Gian Paolo
    Khatib, Rasha
    Nieuwlaat, Robby
    Ding, Chengyi
    Wiercioch, Wojtek
    Mustafa, Reem A.
    Lim, Wendy
    Schunemann, Holger J.
    BLOOD ADVANCES, 2022, 6 (02) : 544 - 567
12345